Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.
Meeting date |
Uploaded by |
Slides |
Comments |
|---|---|---|---|
2 May 2012 |
Julie |
PFIM Interface 3.1 - cours M2R 10-11.pdf |
|
15 May 2012 |
Angelina |
|
|
6 June 2012 |
Joe |
|
|
13 June 2012 |
Joanna |
EMA geriatric workshop - March 2012 - Shepard (submitted 19March).ppt |
Terry Shepard's Slides |
12 October 2012 |
Rollo |
|
|
9 November 2012 |
Joanna |
|
|
13 November 2012 |
Julie |
|
|
14 December 2012 |
Lilia |
Modelling neutrophil dynamics in children following bone marrow transplant |
|
22 Februrary 2013 |
Allienor Berges |
|
|
1 March 2013 |
Rollo |
|
|
28 May 2013 |
Charlotte |
|
List of past meetings:
9 May 2012 |
PUW1 |
Joanna |
Immunology |
16 May 2012 |
WCJ |
Angelina |
Zidovudine PK/PG |
23 May 2012 |
PUW2 |
Jig |
LMWH in pregnancy |
30 May 2012 |
No meeting |
|
|
6 June 2012 |
PUW1 |
Joe |
Antimicrobial PKPD |
13 June 2012 |
PUW1 |
Terry Shepard |
Geriatric PKPD |
20 June 2012 |
PUW2 |
Rollo/Joanna |
Immunology modelling |
27 June 2012 |
No meeting |
|
|
4th July 2012 |
No meeting |
|
|
11th July 2012 |
PUW2 |
Julie |
PAGE review |
18th July 2012 |
PUW2 |
Katie |
Gentamicin in burns |
12/10/12 1pm |
WCA |
Rollo |
Modelling of the immune reconstitution post BMT |
19/10/12 1pm |
PUW3 |
Joe |
Prague Biometrics 2012;68:902-11 |
26/10/12 1pm |
PUW3 |
Charlotte |
NAPPA (Beta lactam pharmacokinetics/pharmacodynamics) plans |
2/11/12 1pm |
PUW3 |
Eva |
Neogent (developing Bayesian therapeutic drug monitoring) progress |
9/11/12 1pm |
PUW3 |
Joanna |
Inference methods course review |
16/11/12 1pm |
PUW2 |
|
General discussion |
23/11/12 1pm |
PUW3 |
Julie |
Covariate selection methods in pharmacokinetic modelling |
30/11/12 1pm |
PUW3 |
Julie |
NCA versus modelling in phase I studies for drugs with long half-life |
7/12/12 1pm |
PUW3 |
|
Goldacre talk |
14/12/12 1pm |
PUW3 |
Lilia |
Neutropenia post-BMT |
4/1/13 1pm |
PUW3 |
|
General discussion |
11/1/13 1pm |
Levinsky |
Joe |
Maraviroc PK |
18/1/13 1pm |
PUW4 |
Andrezj |
PKPD bridging of response between adults and children |
25/1/13 1pm |
PUW3 |
Lilia |
Neutropenia following paediatric BMT |
1/2/13 1pm |
PUW1 |
Mirjam Trame |
Use of PKPD modeling to guide HIV understanding and treatment |
8/2/13 1pm |
PUW3 |
Sami |
Bioequivalence studies and genetic variability |
15/2/13 1pm |
PUW1 |
Liana |
ErbB inhibition for PKD |
22/2/13 1pm |
PUW3 |
Alienor Berges (GSK) |
|
1/3/13 1pm |
PUW4 |
Rollo |
CD4 reconstitution post BMT |
8/3/13 1pm |
PUW3 |
Eva |
Neogent update |
15/3/13 1pm |
PUW4 |
Tafi |
Dose individualisation in HIV/AIDS and TB patients on Efavirenz (EFV). |
22/3/13 1pm |
PUW3 |
Hui Ma |
Genetic components to glucose-insulin response |
26/4/13 1pm |
PUW3 |
Sarit |
FA and bioavailability |
10/5/13 1pm |
PUW3 |
Tafi |
Common adverse drug reactions linked to HIV and/or TB medication: Lipodystrophy, Skin Hypersensitivity, CNS and Peripheral Neuropathy. |
28/5/13 1pm |
PUW1 |
Charlotte |
Use of meta-analysis in evidence synthesis: an example based on dose selection for antibiotics (PAGE talk) |
31/5/13 1pm |
PUW1 |
Rollo |
Modelling immune reconstitution in children post HSCT (PAGE talk) |
7/6/13 1pm |
PUW3 |
Julie |
Penalized regression implementation within the SAEM algorithm to advance high-throughput personalized drug therapy (PAGE talk) |
21/6/13 1pm |
PUW1 |
Bruce Green |
Therapeutic Drug Monitoring |